2Kang Y,Lee J, Min Y, et al. A randomized multi-center phase Ⅱ trial of capecitablne(X) versus S-1 (S) as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer[J]. J clin Oncol,2007,25 (18s) :4546.
3Park Y,kim B, Ryoo B, et al. A phase Ⅱ study of capecitabineplus 3- weekly oxaliplatin as first-line therapy for patients with advanced gastric cancer[J]. Br J Cancer,2006,94 ( 7 ) :959.